India's Pharmaceutical Exports

Country Profile

Eritrea

Eritrea is a developing market for Indian pharmaceuticals — $3.30M in FY 2025–26. Medicines accounts for 68% of shipments, with vaccines contributing $720K.

🇪🇷 $3.30M · 0.9× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$3.30M
Exports FY2025–26 DGCIS
0.9×
Growth FY2015→2026
68%
Medicines Share
4
Product Categories Supplied
12
Years of Trade Data
Eritrea is a developing market for Indian pharmaceuticals — $3.30M in FY 2025–26. Medicines accounts for 68% of shipments, with vaccines contributing $720K.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $2.24M (68.0%) Vaccines $720K (21.8%) Surgical & Hospital Supplies $174K (5.3%) Medicine Ingredients $161K (4.9%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Eritrea in the RBI overseas direct investment dataset (2011–2026).